← All organizations
Highest phase reached
Phase 2
First clinical trial
Jun 1, 2017Last known activity
Oct 31, 2024
Timeline
2010s
- Jun 1, 2017
Quadram Institute— Founded
Drugs by trial phase (30 distinct, 27 trials)
Phase 2 (2 own, 0 via acquisition)
Indications
Recent trials (40)
- NCT06494137CollaboratorN/AOct 31, 2024
- NCT06508424CollaboratorN/AJul 31, 2024
- NCT06291272CollaboratorN/AOct 15, 2023
- NCT04364360CollaboratorN/AJan 1, 2020
- NCT04046653Lead sponsorN/AJul 3, 2019
- NCT04046653Overall official - principal investigatorN/AJul 3, 2019
- NCT03994276CollaboratorN/AJun 24, 2019
- NCT03917693Study chairN/AApr 29, 2019
- NCT03917693Overall official - principal investigatorN/AApr 29, 2019
- NCT03917693Lead sponsorN/AApr 29, 2019
- NCT03691987CollaboratorPhase 2Nov 1, 2018
- NCT05154500CollaboratorN/AAug 29, 2018
- NCT03213288Lead sponsorN/ASep 25, 2017
- NCT03213288Overall official - principal investigatorN/ASep 25, 2017
- NCT02986165CollaboratorN/ASep 1, 2016
Details
- Founded
- Norwich, GB Jun 1, 2017
- Last known activity
- Oct 31, 2024